ArticleJournal of translational medicine2026

Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'".

Bita Rostami-Afshari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.